BioArctic AB (publ) (STO: BIOA.B)
Sweden
· Delayed Price · Currency is SEK
212.00
+2.20 (1.05%)
Jan 3, 2025, 5:29 PM CET
BioArctic AB Employees
BioArctic AB had 88 employees as of December 31, 2023. The number of employees increased by 27 or 44.26% compared to the previous year.
Employees
88
Change (1Y)
27
Growth (1Y)
44.26%
Revenue / Employee
1.61M SEK
Profits / Employee
-2.24M SEK
Market Cap
18.74B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Swedish Orphan Biovitrum AB | 1,772 |
Sectra AB | 1,204 |
Getinge AB | 11,739 |
Camurus AB | 213 |
Medicover AB | 45,316 |
Vitrolife AB | 1,123 |
Bonesupport Holding AB | 118 |
Elekta AB | 4,718 |
BioArctic AB News
- 4 weeks ago - Leqembi® approved in Mexico - PRNewsWire
- 5 weeks ago - Leqembi® launched in South Korea - PRNewsWire
- 7 weeks ago - CHMP issues positive recommendation for approval of lecanemab in the EU - PRNewsWire
- 2 months ago - Eisai updates Leqembi® outlook for fiscal year 2024 (April 2024 - March 2025). Sales now expected to reach JPY 42.5 billion - PRNewsWire
- 2 months ago - Invitation to presentation of BioArctic's third quarter report for July - September 2024 on November 14 at 9.30 a.m. CET - PRNewsWire
- 2 months ago - Lecanemab data presented at CTAD on early initiation and long-term treatment suggest increased patient benefit with maintained safety profile - PRNewsWire
- 2 months ago - Leqembi® revenue totaled JPY 10 billion in the third quarter 2024 - Benzinga
- 2 months ago - Professor Lars Lannfelt, awarded the CTAD Lifetime Achievement Award in recognition for his pioneering work in Alzheimer's Disease - PRNewsWire